At close: December 20 at 5:35:31 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 17 | 10 | 23 | 24 |
| Avg. Estimate | 6.13B | 6.14B | 24.27B | 25.24B |
| Low Estimate | 6.02B | 5.99B | 24.15B | 24.46B |
| High Estimate | 6.24B | 6.29B | 24.39B | 25.99B |
| Year Ago Sales | 6.16B | 6.03B | 24.12B | 24.27B |
| Sales Growth (year/est) | -0.50% | 1.75% | 0.62% | 4.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| UNP.DE | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 11/13/2024 |
| Maintains | Citigroup: Neutral to Neutral | 11/12/2024 |
| Maintains | TD Cowen: Buy to Buy | 10/25/2024 |
| Maintains | Barclays: Overweight to Overweight | 10/25/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 10/25/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 10/25/2024 |